Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-03 2:30 pm Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Hudson Bay Capital Management LP | 3,400,000 5.34% | 3,400,000 (New Position) | View |
| 2021-03-10 07:51 am Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Mohan Pankaj | 942,959 5.5% | 942,959 (New Position) | View |
| 2021-02-16 3:53 pm Sale | 13G | Sonnet BioTherapeutics Holdings, Inc. HOTR | Arena Investors LP | 0 0% | -1,500,000 (Position Closed) | View |
| 2021-02-16 07:32 am Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Altium Capital Management LP | 5,664,728 4.99% | 5,126,638 (+952.75%) | View |
| 2021-01-26 11:21 am Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Empery Asset Management, LP | 5,707,107 4.99% | 5,169,017 (+960.62%) | View |
| 2020-04-21 2:57 pm Purchase | 13D | Sonnet BioTherapeutics Holdings, Inc. SONN | Oz Rey LLC | 42,307 0.46% | 42,307 (New Position) | View |
| 2020-04-10 09:35 am Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Altium Capital Management LP | 538,090 5.8% | 538,090 (New Position) | View |
| 2020-04-07 6:43 pm Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Ezralow Bryan | 555,641 4.97% | 555,641 (New Position) | View |
| 2020-04-07 11:14 am Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Empery Asset Management, LP | 538,090 5.85% | 538,090 (New Position) | View |
| 2020-03-31 1:50 pm Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. HOTR | Arena Investors LP | 1,500,000 9.99% | 1,500,000 (New Position) | View |
| 2020-03-02 7:28 pm Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. HOTR | Ezralow Bryan | 624,349 5.6% | 420,000 (+205.53%) | View |
| 2020-02-10 5:00 pm Purchase | 13G | Sonnet BioTherapeutics Holdings, Inc. HOTR | Ezralow Bryan | 204,349 2.03% | 1,600 (+0.79%) | View |
| 2019-12-02 12:38 pm Purchase | 13D | Sonnet BioTherapeutics Holdings, Inc. HOTR | Oz Rey LLC | 1,200,000 10.64% | 1,200,000 (New Position) | View |
| 2019-11-21 3:09 pm Sale | 13D | Sonnet BioTherapeutics Holdings, Inc. HOTR | SPITCAUFSKY LARRY | 663,473 6.29% | -400,000 (-37.61%) | View |
| 2019-09-03 4:32 pm Unchanged | 13D | Sonnet BioTherapeutics Holdings, Inc. HOTR | SPITCAUFSKY LARRY | 1,063,473 22.11% | 0 (Unchanged) | View |
| 2019-05-23 2:35 pm Purchase | 13D | Sonnet BioTherapeutics Holdings, Inc. HOTR | SPITCAUFSKY LARRY | 1,063,473 22.11% | 511,181 (+92.56%) | View |
| 2018-02-13 11:48 am Sale | 13G | Sonnet BioTherapeutics Holdings, Inc. HOTR | Ezralow Bryan | 202,749 6.7% | -1,068,214 (-84.05%) | View |